/ECOR
ECOR Stock - electroCore, Inc.
Healthcare|Medical - DevicesNASDAQ
$4.60+4.07%
+$0.18 (+4.07%) • Dec 19
56
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.7
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $5.06
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for ECOR
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$4.55 – $4.65
TARGET (TP)$5.29
STOP LOSS$4.23
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.34
52W High$19.49
52W Low$4.16
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $25.18M | $16.03M | $8.59M | $5.45M | $3.50M |
| Gross Profit | $21.40M | $13.23M | $6.98M | $4.07M | $1.76M |
| Gross Margin | 85.0% | 82.5% | 81.2% | 74.6% | 50.3% |
| Operating Income | $-12,162,000 | $-18,805,000 | $-22,874,000 | $-20,043,000 | $-24,748,511 |
| Net Income | $-11,886,000 | $-18,834,000 | $-22,162,000 | $-17,218,000 | $-23,511,050 |
| Net Margin | -47.2% | -117.5% | -257.9% | -315.9% | -672.5% |
| EPS | $-1.59 | $-3.42 | $-4.69 | $-4.36 | $-9.04 |
Company Overview
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld device for regular or intermittent use over many years. The company was incorporated in 2005 and is headquartered in Rockaway, New Jersey.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
ECORBeat Rate
26%
Last 19 quarters
Avg Surprise
-5.7%
EPS vs Estimate
Beats / Misses
5/12
2 met exactly
Latest EPS
$-0.40
Q4 2025
EPS Surprise History
Q1 24
-10.9%
$-0.61vs$-0.55
Q2 24
-6.0%
$-0.53vs$-0.50
Q3 24
+2.6%
$-0.38vs$-0.39
Q4 24
-6.9%
$-0.31vs$-0.29
Q1 25
-17.6%
$-0.40vs$-0.34
Q2 25
+16.1%
$-0.47vs$-0.56
Q3 25
-9.4%
$-0.35vs$-0.32
Q4 25
-11.1%
$-0.40vs$-0.36
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Mar 11, 2026 | $-0.35 | — | — | — |
Q4 2025 | Nov 5, 2025 | $-0.36 | $-0.40 | -11.1% | ✗ MISS |
Q3 2025 | Aug 6, 2025 | $-0.32 | $-0.35 | -9.4% | ✗ MISS |
Q2 2025 | May 7, 2025 | $-0.56 | $-0.47 | +16.1% | ✓ BEAT |
Q1 2025 | Mar 12, 2025 | $-0.34 | $-0.40 | -17.6% | ✗ MISS |
Q4 2024 | Nov 13, 2024 | $-0.29 | $-0.31 | -6.9% | ✗ MISS |
Q3 2024 | Aug 7, 2024 | $-0.39 | $-0.38 | +2.6% | ✓ BEAT |
Q2 2024 | May 8, 2024 | $-0.50 | $-0.53 | -6.0% | ✗ MISS |
Q1 2024 | Mar 13, 2024 | $-0.55 | $-0.61 | -10.9% | ✗ MISS |
Q4 2023 | Nov 8, 2023 | $-0.64 | $-0.68 | -6.3% | ✗ MISS |
Q3 2023 | Aug 9, 2023 | $-1.00 | $-1.03 | -3.0% | ✗ MISS |
Q2 2023 | May 3, 2023 | $-1.00 | $-1.24 | -24.0% | ✗ MISS |
Q1 2023 | Mar 8, 2023 | $-1.11 | $-1.22 | -9.9% | ✗ MISS |
Q4 2022 | Nov 3, 2022 | $-1.05 | $-1.20 | -14.3% | ✗ MISS |
Q3 2022 | Aug 4, 2022 | $-1.20 | $-1.20 | 0.0% | = MET |
Q2 2022 | May 5, 2022 | $-0.75 | $-1.20 | -60.0% | ✗ MISS |
Q1 2022 | Mar 10, 2022 | $-1.05 | $-1.05 | 0.0% | = MET |
Q4 2021 | Nov 4, 2021 | $-1.20 | $-0.90 | +25.0% | ✓ BEAT |
Q3 2021 | Aug 5, 2021 | $-1.65 | $-1.35 | +18.2% | ✓ BEAT |
Q2 2021 | May 6, 2021 | $-1.80 | $-1.65 | +8.3% | ✓ BEAT |
Latest News
ElectroCore Granted Patent # US 12469610 B2 For "SYSTEMS AND METHODS FOR TREATING BLOOD CLOTS WITH NERVE STIMULATION"
📈 PositiveBenzinga•Nov 11, 2025, 08:53 PM
electroCore Sees FY2025 Sales $31.500M-$32.500M vs $30.749M Est
📈 PositiveBenzinga•Nov 6, 2025, 12:00 AM
electroCore Q3 EPS $(0.40), Inline, Sales $8.700M Beat $7.843M Estimate
📈 PositiveBenzinga•Nov 5, 2025, 09:14 PM
electroCore Announces Publication Of Peer-Reviewed Study In Frontiers In Neurology Demonstrating Effectiveness Of gammaCore nVNS In Reducing Persistent Symptoms Associated With mTBI
📈 PositiveBenzinga•Sep 30, 2025, 12:14 PM
electroCore Announces Its GammaCore Sapphire Non-Invasive Vagus Nerve Stimulation Device Has Been Included In Long-Term Reimbursement Policy By Belgium's National Institute For Health And Disability Insurance
📈 PositiveBenzinga•Sep 29, 2025, 12:12 PM
Frequently Asked Questions about ECOR
What is ECOR's current stock price?
electroCore, Inc. (ECOR) is currently trading at $4.60 per share. The stock has moved +4.07% today.
What is the analyst price target for ECOR?
No analyst price targets are currently available for this stock.
What sector is electroCore, Inc. in?
electroCore, Inc. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the NASDAQ exchange.
What is ECOR's market cap?
electroCore, Inc. has a market capitalization of $0.04 billion, making it a small-cap company.
Does ECOR pay dividends?
No, electroCore, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBTAI
BioXcel Therapeutics, Inc.
$1.73
Mkt Cap: $0.0B
HYPD
Hyperion DeFi, Inc.
$3.67
Mkt Cap: $0.0B
MAIA
MAIA Biotechnology, Inc.
$1.22
Mkt Cap: $0.0B
MYO
Myomo, Inc.
$0.93
Mkt Cap: $0.0B
NMTC
NeuroOne Medical Technologies Corporation
$0.73
Mkt Cap: $0.0B
PYPD
PolyPid Ltd.
$3.97
Mkt Cap: $0.0B
RBOT
Vicarious Surgical Inc.
$2.17
Mkt Cap: $0.0B
RNXT
RenovoRx, Inc.
$0.93
Mkt Cap: $0.0B
YI
111, Inc.
$3.69
Mkt Cap: $0.0B
ZYXI
Zynex, Inc.
$0.29
Mkt Cap: $0.0B
Explore stocks similar to ECOR for comparison